Comment on: IgG4-related disease presenting with raised serum IgG2—real timeline of IgG4-RD?: reply

Comment on: IgG4-related disease presenting with raised serum IgG2—real timeline of IgG4-RD?:... Sir, We note with interest the response from Mattman et al. [1]. We agree that serum IgG subclass measurement is known to be associated with potential analytical errors as described. The methodology for serial IgG subclass measurement in this case was the binding site assays for the Siemens BNII™ nephelometer (latex enhanced for IgG3 and IgG4). The settings were changed between 2014 and 2015 to correct for antigen excess errors. We also agree that patients historically assessed as unlikely to have the disease, based solely on a low or normal serum IgG4 concentration, should be reassessed. Our previous work, however [2], has demonstrated, using double staining immunohistochemistry, that in patients with IgG4-related orbital disease there is a real elevation of tissue IgG2 plasma cells, distinct from tissue IgG4. It is still our belief, therefore, that the role of both serum and tissue IgG2 in the context of IgG4-RD may not be solely the result of analytical error and assay cross-reactivity. It is a phenomenon that requires further exploration and explanation. Funding: No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this manuscript. Disclosure statement: The authors have declared no conflicts of interest. References 1 Mattman A , Chen LYC , van der Gugten G et al. Comment on: IgG4-related disease presenting with raised serum IgG2—real timeline of IgG4-RD? Rheumatology 2018 ; 57 : 1125 – 6 . 2 Chan ASY , Mudhar H , Shen SY et al. Serum IgG2 and tissue IgG2 plasma cell elevation in orbital IgG4-related disease: potential use in IgG4-RD assessment . Br J Ophthal 2017 ; 101 : 1576 – 82 . Google Scholar CrossRef Search ADS © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices) http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Rheumatology Oxford University Press

Comment on: IgG4-related disease presenting with raised serum IgG2—real timeline of IgG4-RD?: reply

Rheumatology , Volume Advance Article (6) – Mar 23, 2018

Loading next page...
 
/lp/ou_press/comment-on-igg4-related-disease-presenting-with-raised-serum-igg2-real-0qRGfe142z
Publisher
Oxford University Press
Copyright
© The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com
ISSN
1462-0324
eISSN
1462-0332
D.O.I.
10.1093/rheumatology/key045
Publisher site
See Article on Publisher Site

Abstract

Sir, We note with interest the response from Mattman et al. [1]. We agree that serum IgG subclass measurement is known to be associated with potential analytical errors as described. The methodology for serial IgG subclass measurement in this case was the binding site assays for the Siemens BNII™ nephelometer (latex enhanced for IgG3 and IgG4). The settings were changed between 2014 and 2015 to correct for antigen excess errors. We also agree that patients historically assessed as unlikely to have the disease, based solely on a low or normal serum IgG4 concentration, should be reassessed. Our previous work, however [2], has demonstrated, using double staining immunohistochemistry, that in patients with IgG4-related orbital disease there is a real elevation of tissue IgG2 plasma cells, distinct from tissue IgG4. It is still our belief, therefore, that the role of both serum and tissue IgG2 in the context of IgG4-RD may not be solely the result of analytical error and assay cross-reactivity. It is a phenomenon that requires further exploration and explanation. Funding: No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this manuscript. Disclosure statement: The authors have declared no conflicts of interest. References 1 Mattman A , Chen LYC , van der Gugten G et al. Comment on: IgG4-related disease presenting with raised serum IgG2—real timeline of IgG4-RD? Rheumatology 2018 ; 57 : 1125 – 6 . 2 Chan ASY , Mudhar H , Shen SY et al. Serum IgG2 and tissue IgG2 plasma cell elevation in orbital IgG4-related disease: potential use in IgG4-RD assessment . Br J Ophthal 2017 ; 101 : 1576 – 82 . Google Scholar CrossRef Search ADS © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices)

Journal

RheumatologyOxford University Press

Published: Mar 23, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off